$45

Juve Eyes PN 1% Skin Booster – Targeted Rejuvenation for the Periorbital Area

Product Description

Juve Eyes PN 1% Skin Booster is a precision-formulated injectable designed for revitalizing the delicate under-eye region. Containing 1% purified polynucleotides (PN) derived from salmon DNA, it encourages cellular repair, enhances elasticity, and visibly reduces dark circles and puffiness. This advanced skin booster restores a refreshed, youthful appearance without the need for surgery.

Formulation

• Active Ingredient: Polynucleotides (PN) 10 mg/mL – DNA fragments that stimulate collagen regeneration and tissue repair at the cellular level.

• Supporting Ingredients: Aqua (Water), Sodium Chloride, Sodium Phosphate Monobasic Dihydrate, Disodium Hydrogen Phosphate Dihydrate – for isotonic balance and pH stability.

• Appearance: Clear, colorless injectable solution

• Origin: Manufactured in South Korea under strict GMP protocols

Benefits

• Reduces dark circles, puffiness, and under-eye bags

• Smooths fine lines and crow’s feet

• Improves hydration and skin tone in the periorbital area

• Restores firmness and radiance to delicate eye-area skin

• Non-invasive alternative to surgical eye rejuvenation

Scope of Application

• Under-eye pigmentation and hollowness

• Fine lines and early signs of aging

• Skin laxity around the eyes

• Overall rejuvenation of the periorbital area

Indication

• Ideal for patients seeking non-surgical eye rejuvenation

• Suitable for treating signs of fatigue and aging around the eyes

• Recommended for both preventive and corrective aesthetic care

Duration of Effect

• Initial Effects: Visible within 3–5 days post-injection

• Treatment Course: Typically 3 sessions spaced 2–3 weeks apart

• Results Duration: Effects last up to 12 months with maintenance

Packaging and Specifications

• Volume: 2 mL per pre-filled syringe

• Packaging: 1 syringe per box

• Storage: Store at 1–30°C in a dry place, away from direct light

• Shelf Life: Refer to product packaging

• Manufacturer: BNC Global, South Korea